Unilateral laparoscopic retroperitoneal lymphadenectomy for clinical Stage I nonseminomatous testicular cancer

G. Giusti, P. Beltrami, C. Tallarigo, G. Bianchi, G. Mobilio

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Since June 1993, unilateral laparoscopic retroperitoneal lymph-node dissection (LRPLND) has been performed in six patients with clinical Stage I nonseminomatous germ-cell tumors (NSGCT). All of the patients had undergone prior radical orchiectomy. The testicular cancer was left-sided in three cases and right-sided in three cases. Preoperative staging by means of tumor marker assessment, CT scan of the chest and abdomen, and chest radiography was unremarkable for metastatic disease. All procedures were accomplished without any complications in a mean time of 325 minutes (275-420 minutes). The estimated perioperative and postoperative blood loss was minimal, and none of the patients required blood transfusion. In the case of the first patient, the hospital stay was 18 days because of a widespread subcutaneous emphysema. In the remaining five cases, the average hospitalization was 4.8 days (range 4-6 days). The patients resumed normal activities within 12 to 27 days (mean 16.16 days) postoperatively. The mean number of lymph nodes removed was 6.8 (range 5-9). Histologic examination of these nodes revealed microscopic metastases from embryonal carcinoma in two patients, both of whom were subjected to adjuvant chemotherapy. The mean follow-up period is 27.1 months (range 12-42 months). To date, no relapses have been observed. In accordance with other reports, we believe that LRPLND is both feasible and effective. However, larger and more comprehensive studies with long-term follow-up are required to determine whether this approach is reliable and definitely superior to standard open surgery in the management of clinical Stage I NSGCT.

Original languageEnglish
Pages (from-to)561-566
Number of pages6
JournalJournal of Endourology
Volume12
Issue number6
Publication statusPublished - Dec 1998

Fingerprint

Testicular Neoplasms
Lymph Node Excision
Thorax
Embryonal Carcinoma
Subcutaneous Emphysema
Postoperative Hemorrhage
Orchiectomy
Adjuvant Chemotherapy
Tumor Biomarkers
Radiography
Blood Transfusion
Abdomen
Length of Stay
Hospitalization
Lymph Nodes
Neoplasm Metastasis
Recurrence

ASJC Scopus subject areas

  • Urology

Cite this

Giusti, G., Beltrami, P., Tallarigo, C., Bianchi, G., & Mobilio, G. (1998). Unilateral laparoscopic retroperitoneal lymphadenectomy for clinical Stage I nonseminomatous testicular cancer. Journal of Endourology, 12(6), 561-566.

Unilateral laparoscopic retroperitoneal lymphadenectomy for clinical Stage I nonseminomatous testicular cancer. / Giusti, G.; Beltrami, P.; Tallarigo, C.; Bianchi, G.; Mobilio, G.

In: Journal of Endourology, Vol. 12, No. 6, 12.1998, p. 561-566.

Research output: Contribution to journalArticle

Giusti, G, Beltrami, P, Tallarigo, C, Bianchi, G & Mobilio, G 1998, 'Unilateral laparoscopic retroperitoneal lymphadenectomy for clinical Stage I nonseminomatous testicular cancer', Journal of Endourology, vol. 12, no. 6, pp. 561-566.
Giusti, G. ; Beltrami, P. ; Tallarigo, C. ; Bianchi, G. ; Mobilio, G. / Unilateral laparoscopic retroperitoneal lymphadenectomy for clinical Stage I nonseminomatous testicular cancer. In: Journal of Endourology. 1998 ; Vol. 12, No. 6. pp. 561-566.
@article{796205353dd94927bf0d0ee92da0f1f0,
title = "Unilateral laparoscopic retroperitoneal lymphadenectomy for clinical Stage I nonseminomatous testicular cancer",
abstract = "Since June 1993, unilateral laparoscopic retroperitoneal lymph-node dissection (LRPLND) has been performed in six patients with clinical Stage I nonseminomatous germ-cell tumors (NSGCT). All of the patients had undergone prior radical orchiectomy. The testicular cancer was left-sided in three cases and right-sided in three cases. Preoperative staging by means of tumor marker assessment, CT scan of the chest and abdomen, and chest radiography was unremarkable for metastatic disease. All procedures were accomplished without any complications in a mean time of 325 minutes (275-420 minutes). The estimated perioperative and postoperative blood loss was minimal, and none of the patients required blood transfusion. In the case of the first patient, the hospital stay was 18 days because of a widespread subcutaneous emphysema. In the remaining five cases, the average hospitalization was 4.8 days (range 4-6 days). The patients resumed normal activities within 12 to 27 days (mean 16.16 days) postoperatively. The mean number of lymph nodes removed was 6.8 (range 5-9). Histologic examination of these nodes revealed microscopic metastases from embryonal carcinoma in two patients, both of whom were subjected to adjuvant chemotherapy. The mean follow-up period is 27.1 months (range 12-42 months). To date, no relapses have been observed. In accordance with other reports, we believe that LRPLND is both feasible and effective. However, larger and more comprehensive studies with long-term follow-up are required to determine whether this approach is reliable and definitely superior to standard open surgery in the management of clinical Stage I NSGCT.",
author = "G. Giusti and P. Beltrami and C. Tallarigo and G. Bianchi and G. Mobilio",
year = "1998",
month = "12",
language = "English",
volume = "12",
pages = "561--566",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Unilateral laparoscopic retroperitoneal lymphadenectomy for clinical Stage I nonseminomatous testicular cancer

AU - Giusti, G.

AU - Beltrami, P.

AU - Tallarigo, C.

AU - Bianchi, G.

AU - Mobilio, G.

PY - 1998/12

Y1 - 1998/12

N2 - Since June 1993, unilateral laparoscopic retroperitoneal lymph-node dissection (LRPLND) has been performed in six patients with clinical Stage I nonseminomatous germ-cell tumors (NSGCT). All of the patients had undergone prior radical orchiectomy. The testicular cancer was left-sided in three cases and right-sided in three cases. Preoperative staging by means of tumor marker assessment, CT scan of the chest and abdomen, and chest radiography was unremarkable for metastatic disease. All procedures were accomplished without any complications in a mean time of 325 minutes (275-420 minutes). The estimated perioperative and postoperative blood loss was minimal, and none of the patients required blood transfusion. In the case of the first patient, the hospital stay was 18 days because of a widespread subcutaneous emphysema. In the remaining five cases, the average hospitalization was 4.8 days (range 4-6 days). The patients resumed normal activities within 12 to 27 days (mean 16.16 days) postoperatively. The mean number of lymph nodes removed was 6.8 (range 5-9). Histologic examination of these nodes revealed microscopic metastases from embryonal carcinoma in two patients, both of whom were subjected to adjuvant chemotherapy. The mean follow-up period is 27.1 months (range 12-42 months). To date, no relapses have been observed. In accordance with other reports, we believe that LRPLND is both feasible and effective. However, larger and more comprehensive studies with long-term follow-up are required to determine whether this approach is reliable and definitely superior to standard open surgery in the management of clinical Stage I NSGCT.

AB - Since June 1993, unilateral laparoscopic retroperitoneal lymph-node dissection (LRPLND) has been performed in six patients with clinical Stage I nonseminomatous germ-cell tumors (NSGCT). All of the patients had undergone prior radical orchiectomy. The testicular cancer was left-sided in three cases and right-sided in three cases. Preoperative staging by means of tumor marker assessment, CT scan of the chest and abdomen, and chest radiography was unremarkable for metastatic disease. All procedures were accomplished without any complications in a mean time of 325 minutes (275-420 minutes). The estimated perioperative and postoperative blood loss was minimal, and none of the patients required blood transfusion. In the case of the first patient, the hospital stay was 18 days because of a widespread subcutaneous emphysema. In the remaining five cases, the average hospitalization was 4.8 days (range 4-6 days). The patients resumed normal activities within 12 to 27 days (mean 16.16 days) postoperatively. The mean number of lymph nodes removed was 6.8 (range 5-9). Histologic examination of these nodes revealed microscopic metastases from embryonal carcinoma in two patients, both of whom were subjected to adjuvant chemotherapy. The mean follow-up period is 27.1 months (range 12-42 months). To date, no relapses have been observed. In accordance with other reports, we believe that LRPLND is both feasible and effective. However, larger and more comprehensive studies with long-term follow-up are required to determine whether this approach is reliable and definitely superior to standard open surgery in the management of clinical Stage I NSGCT.

UR - http://www.scopus.com/inward/record.url?scp=0032436798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032436798&partnerID=8YFLogxK

M3 - Article

C2 - 9895263

AN - SCOPUS:0032436798

VL - 12

SP - 561

EP - 566

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 6

ER -